Crohn's & Colitis Foundation presents Sixth Annual IBD INNOVATE Conference- Propelling IBD Product Development in Cambridge, MA April 9-10
Meeting Announcement
The Crohn's & Colitis Foundation seeks to accelerate the discovery and development of novel products with the potential to address the unmet needs of the 1 in 100 Americans affected by Crohn’s disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD). From April 9-10, IBD INNOVATE: Product Development for Crohn’s & Colitis™, will spotlight innovative IBD products and bring key stakeholders together in Cambridge, MA to showcase emerging advances in IBD care.
A pivotal event in Rheumatology Research and Innovation
800ZR, Coherent PON, Linear Pluggable Optics (LPO), multicore fiber, AI and the data center, quantum networking and more will be hot topics at OFC.
The 7th World Conference on Targeting Phage Therapy 2024 is set to take place on June 20-21 at the Corinthia Palace Malta, introducing the latest advancements within the field of phage research and therapy.
Robert T. Schooley, M.D., Professor of Medicine at the University of California, San Diego, and Co-Director of the Center for Innovative Phage Applications and Therapeutics, will lead the discourse, presenting insights and strategies essential to Phage Therapy in his talk titled "Phage Therapeutics 2024: Essential Translational Research Components for Clinical Trials."
The 17th World Congress on Polyphenols Applications 2024 will be organized on September 19-20, 2024, at the Università degli Studi di Milano Statale in Italy. This conference aims to bridge the gap between the latest scientific research on polyphenols and their practical applications for promoting health and well-being, welcoming researchers, industry professionals, and academics to share novel insights and advancements in the field of polyphenols.
Polyphenols Applications Scientific Committee emphasized the importance of the event: “The study of polyphenols has made significant advances in recent years, and our understanding of their potential to improve human health continues to grow. This congress aims to share novel insights into polyphenols and their impact on human health, with the goal of translating scientific discoveries into real-world applications.”
The 1st International Forum on Challenges of and Responses to Zoonoses will be held at Shanxi Agricultural University, Taigu District, Jinzhong, China on October 29 – 31, 2024.
Early bird registration: April 30th, 2024 https://conference.zoonoses-journal.org/
A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting in Salt Lake City. The traditional treatment options of radiation or surgery often come with a risk of side effects, including urinary incontinence and erectile dysfunction that cause significant morbidity and adverse lifestyle effects. Researchers said that some patients now have a durable alternative for whole-gland treatment with MRI-guided transurethral ultrasound ablation (TULSA) that does not preclude future treatment with surgery or radiation.
A minimally invasive technique that uses ice to freeze and destroy small, cancerous tumors has now been proven effective for breast cancer patients with large tumors, providing a new treatment path for those who are not candidates for surgery, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting in Salt Lake City.
Early intervention with a minimally invasive treatment called uterine artery embolization (UAE) can help women avoid hysterectomy due to severe bleeding after childbirth, according to a new study being presented at the Society of Interventional Radiology Annual Scientific Meeting in Salt Lake City.
A study aiming to determine a set of oral health care services to be delivered within the comprehensive outpatient benefit package of the National Health Insurance Program (NHIP) of the Philippines was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research.
A study aiming to determine if a relationship exists between constructs of Indigeneity and untreated caries in First Nations children in Manitoba and Ontario, controlling for selected was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeing of the Canadian Association for Dental Research.
A study aiming to develop a Lipid nanoparticles (LNP) platform for treating oral squamous cell carcinoma (OSCC) utilizing p53 mRNA was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research.